SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Aspira Women's Health entered into a private placement securities purchase agreement on June 5, 2026, issuing 3,300,000 shares of common stock and warrants to purchase 4,455,000 additional shares to accredited and institutional investors for approximately $1.485 million in gross proceeds.
View raw filing on EDGAR →The filing discloses unregistered sales of equity securities under Item 3.02, specifically: (1) exercise of 416,667 common stock purchase warrants for $166,667 gross proceeds, with issuance of 416,667 additional incentive warrants; and (2) exercise of 100,000 performance warrants for $100. These transactions are exempt from registration (Regulation S and Rule 506(b)), and the incentive warrants represent dilutive equity issuances. The scale of warrant exercises and the incentive program designed to encourage early exercise of up to 5.7 million outstanding warrants signal material dilution to existing shareholders.
View raw filing on EDGAR →The filing announces a $1.2 billion private offering of senior notes due 2031 and 2034, offered to qualified institutional buyers under Rule 144A and Regulation S. While this is a material debt issuance, the event is primarily a debt offering rather than an equity issuance. The dilutive_issuance category is typically reserved for unregistered equity sales (PIPEs, convertibles, ATM offerings). This disclosure is more accurately characterized as debt financing activity, which does not fit neatly into the provided taxonomy and may be better classified as other_material.
View raw filing on EDGAR →Allegiant Travel commenced a $500 million private offering of senior secured notes due 2031 to qualified institutional buyers under Rule 144A and Regulation S, concurrent with a tender offer for $403 million of existing 2027 notes.
View raw filing on EDGAR →The filing discloses two unregistered equity issuances: (1) 398,666 shares issued as consideration for the Lyphe Group acquisition under Section 4(a)(2), and (2) 1,214,186 shares issued in a debt-for-equity exchange under Section 3(a)(9). Together, these represent approximately 1.6 million shares of dilutive issuance, with the debt exchange alone converting $6 million of convertible notes. This is material to investors as it increases share count and dilutes existing shareholders.
View raw filing on EDGAR →Allegiant Travel announced a private offering of $650.0 million in Senior Secured Notes due 2031, increased from the previously announced $500.0 million. The offering is being conducted under Rule 144A and Regulation S as an unregistered private placement to qualified institutional buyers and non-U.S. persons. While technically debt rather than equity, this represents a material capital-raising transaction that increases the company's financial obligations and would affect a reasonable investor's assessment of leverage and financial structure.
View raw filing on EDGAR →Cheniere Partners closed a $1.75 billion private placement of senior notes on June 9, 2026, consisting of $1 billion 2036 Notes and $750 million 2056 Notes, pursuant to supplemental indentures. This material debt financing activity affects the company's capital structure and financial obligations.
View raw filing on EDGAR →Novanta entered into a Securities Purchase Agreement for a private placement of approximately 2,142,857 common shares at $140.00 per share for approximately $300 million, representing approximately 6% dilution to existing shareholders. The unregistered equity sale under Section 4(a)(2) was announced with forward-looking statements regarding registration of the shares.
View raw filing on EDGAR →MSD Investment Corp. priced a $300 million offering of 6.375% notes due 2029 in a private placement to qualified institutional buyers under Rule 144A and Regulation S. While this is a material debt issuance that would affect investor assessment of the company's capital structure and leverage, the event does not fit cleanly into the provided taxonomy. The "dilutive_issuance" category is defined as unregistered equity sales (private placements, PIPEs, convertible notes, ATM offerings), but this disclosure concerns debt notes, not equity. This is more accurately a debt financing event, which falls under "other_material" as it lacks a dedicated 8-K classification but materially affects the registrant's financial position.
View raw filing on EDGAR →The filing discloses an unregistered sale of 2,701,420 shares of common stock by certain stockholders acquired in connection with Ondas Inc.'s acquisition of Omnisys Ltd. The shares are being registered for resale via a prospectus supplement to an S-3ASR registration statement. This represents a dilutive equity issuance material to investors assessing ownership and capital structure, particularly given the acquisition context and the substantial share count involved.
View raw filing on EDGAR →Rain Enhancement Technologies issued 10,283,984 shares of Class A Common Stock unregistered, including a $4,000,000 debt-to-equity conversion from RHY Management LLC (affiliated with Chairman Harry You) and grants to officers, directors, advisors, and consultants, relying on Section 4(a)(2) and Regulation D exemptions. This represents material dilution to existing shareholders and a significant capital structure change.
View raw filing on EDGAR →Aditxt entered into a Note Purchase Agreement on June 3, 2026, issuing senior secured convertible notes with an aggregate principal amount of approximately $725,000 in cash proceeds plus consolidation of existing notes totaling $4.4+ million to accredited investors under Section 4(a)(2) and Regulation D Rule 506(b). The unregistered private placement of convertible securities is material to investors due to ownership dilution and capital structure effects.
View raw filing on EDGAR →BRC Group Holdings disclosed unregistered sales of equity securities under Item 3.02 that exceeded 5% of outstanding shares. The Company issued 2,060,683 shares of Common Stock in two private exchanges (May 14 and June 4, 2026) in exchange for cancellation of senior notes, representing approximately 5.1% of the 40.2 million shares outstanding as of June 4, 2026. This is a classic dilutive issuance under Section 3(a)(9) of the Securities Act, material to investors assessing ownership dilution and the Company's capital structure.
View raw filing on EDGAR →The filing discloses unregistered issuance of 10,670,000 shares of common stock to five independent contractors as compensation for consulting services, plus an additional 700,000 shares in a settlement agreement, totaling 11,370,000 shares. These are issued as restricted securities under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, which is the classic structure for dilutive private placements. Item 3.02 is the designated disclosure item for unregistered equity sales, and the magnitude of shares issued represents material dilution to existing shareholders.
View raw filing on EDGAR →The filing discloses the issuance of $458 million aggregate principal amount of 1.250% Convertible Senior Notes due 2032, with an additional $58 million issued upon full exercise of an option by initial purchasers. The Notes are convertible into common stock at an initial conversion price of approximately $7.41 per share (134.9073 shares per $1,000 principal). This is a material dilutive issuance of convertible debt securities that will result in equity dilution upon conversion. While technically a debt issuance under Item 1.01, the convertible feature and substantial principal amount make this a material capital-raising event with significant dilutive potential to existing shareholders.
View raw filing on EDGAR →LiqTech entered into an Underwriting Agreement on June 4, 2026, for a registered public offering of 20,000,000 shares of common stock at $1.00 per share, with a 3,000,000 share over-allotment option. The offering closed on June 8, 2026, generating approximately $18.0 million in net proceeds for debt repayment and working capital.
View raw filing on EDGAR →LiqTech issued 3,000,000 shares of common stock on June 8, 2026, in a private placement exempt under Section 4(a)(2) and Rule 506(b), in exchange for cancellation of $3.0 million in senior promissory notes.
View raw filing on EDGAR →VolitionRx entered into a securities purchase agreement on June 7, 2026, to sell 2,960,000 shares of common stock and 1,480,000 common stock purchase warrants at $1.55 per unit, raising approximately $4.1 million in net proceeds with additional dilutive potential from warrant exercises.
View raw filing on EDGAR →22nd Century Group issued new warrant inducement agreements (Inducement Warrants) to purchase common stock at a significantly reduced exercise price of $0.4626 compared to the original $3.57 exercise price. The Inducement Warrants and underlying shares are unregistered equity securities issued in reliance on Section 4(a)(2) exemption, materially affecting shareholder ownership and dilution.
View raw filing on EDGAR →Applied Digital announced a $1.59 billion private offering of senior secured notes due 2031 by its subsidiary APLD ComputeCo 3 LLC, disclosed under Item 8.01. While technically debt rather than equity, this represents a material capital raise that will dilute existing shareholders' ownership percentage and is disclosed as a significant financing event. The offering is substantial in size and intended to fund major infrastructure development (150 MW at Ellendale) and repay bridge financing.
View raw filing on EDGAR →The filing discloses an unregistered sale of 79,618 shares of common stock to CEO Steven Rossi on June 5, 2026, at $0.6280 per share for $50,000.10, relying on Section 4(a)(2) exemption. Although the purchase price was satisfied through offset of accrued bonus compensation rather than cash, this is a dilutive equity issuance to an insider that would materially affect shareholder ownership and is properly classified under Item 3.02 (Unregistered Sales of Equity Securities).
View raw filing on EDGAR →The filing discloses two unregistered equity issuances: (1) a PIPE transaction with Smart Dynamics Technology Limited for 20 million shares and 160 million warrants at $10 million aggregate consideration, and (2) a stock purchase agreement with Alset Inc. (the majority shareholder) for 250,000 shares at $500,000. Both securities are explicitly noted as unregistered under the Securities Act, relying on Section 4(a)(2) and Regulation D exemptions. The PIPE represents substantial dilution and is a classic private placement financing event material to investors.
View raw filing on EDGAR →The filing discloses an At-The-Market (ATM) offering under which Enveric Biosciences filed a prospectus supplement on June 9, 2026 to offer an additional $2,425,000 of common stock shares pursuant to an ATM Agreement with H.C. Wainwright & Co., LLC dated April 9, 2025. The company has already sold $4,483,711.04 under this agreement. This is a dilutive equity issuance that would materially affect shareholders through equity dilution and is a strong signal of capital-raising activity typical of small- and mid-cap issuers.
View raw filing on EDGAR →Applied Digital's subsidiary APLD ComputeCo 3 LLC priced a $1.59 billion offering of senior secured notes due 2031 at par (100%). While technically debt rather than equity, this represents a material capital raise that increases the company's financial obligations and dilutes equity holders' ownership percentage. The proceeds fund construction of critical infrastructure (150 MW at Ellendale) and repay bridge financing, making this a material financing event that would affect investor assessment of the registrant's capital structure and leverage.
View raw filing on EDGAR →Edgemode issued a $300,000 convertible promissory note to an accredited investor in a private placement under Section 4(a)(2), with conversion rights at $0.01 per share (resettable downward to $0.0075 or lower based on stock price triggers). This is a dilutive equity issuance that raises capital through convertible debt with significant downside conversion price protection for the investor, characteristic of a PIPE-like financing. The material nature is underscored by the short maturity (August 3, 2026), high interest rate (12% plus $50,000 lump-sum charge), and aggressive anti-dilution provisions that would materially dilute existing shareholders upon conversion.
View raw filing on EDGAR →Redwire entered into an Equity Distribution Agreement (ATM offering) on June 9, 2026, authorizing the sale of up to $500 million in common stock shares through multiple agents. This is a classic at-the-market offering under Rule 415, which represents a dilutive equity issuance that would materially affect shareholder ownership and the total mix of information available to investors. The filing explicitly discloses the offering structure, agent commissions, and intended use of proceeds.
View raw filing on EDGAR →Southern Company entered into an Equity Distribution Agreement on June 8, 2026, establishing a framework to offer and sell shares of common stock through multiple sales agents, including forward sale agreements and collared forward transactions. This is a dilutive equity issuance mechanism that allows the company to raise capital by selling shares at future dates, with potential for significant dilution to existing shareholders through both direct share sales and forward transactions involving borrowed shares.
View raw filing on EDGAR →Cipher Digital announced its intention to offer $810.0 million aggregate principal amount of senior secured notes through subsidiary Stingray Compute LLC in a private offering to qualified institutional buyers under Rule 144A and Regulation S. This substantial capital-raising activity is material to investors.
View raw filing on EDGAR →Standard BioTools will issue unregistered Common Stock in connection with the Merger Agreement, relying on Section 4(a)(2) and Regulation D exemptions. This equity issuance materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →Brookfield Private Equity Fund LP sold approximately $8.085 million in unregistered limited partnership units (Class S and Class I) on May 1, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D, diluting existing unit holders' ownership interests.
View raw filing on EDGAR →Elite Express completed a private placement of 32,000,000 shares of Class A Common Stock at $0.25 per share for $8,000,000 in gross proceeds on June 4, 2026, conducted offshore under Regulation S to non-U.S. investors.
View raw filing on EDGAR →The filing discloses unregistered sales of convertible promissory notes totaling $225,000 in principal (with $247,500 repayment obligation) under Item 3.02. The 2026 Bridge Notes are convertible into common stock at $0.15 per share and were sold pursuant to Section 4(a)(2) and Regulation D exemptions. Additionally, Item 8.01 describes a non-binding term sheet for a $30 million Equity Line of Credit (ELOC) facility with registration planned via Form S-1, indicating substantial dilutive equity issuance activity. This is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →Ciena announced its intention to issue $2.0 billion of convertible senior notes due 2031 in a private placement under Rule 144A, with an additional $300 million option. The convertible notes are inherently dilutive securities that will convert to common stock, and the filing explicitly discloses concurrent warrant transactions relating to shares of common stock. This is a material capital-raising event typical of dilutive issuances at mid-cap technology companies.
View raw filing on EDGAR →Village Farms entered into securities purchase agreements on June 5, 2026 for a registered direct offering of 7,500,000 common shares at US$2.00 per share, generating approximately US$15 million in gross proceeds. This is a registered equity issuance that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing activities.
View raw filing on EDGAR →Strategy Inc sold 1,409,600 shares of Class A Common Stock under its at-the-market offering program during June 1-7, 2026, generating $181.0 million in net proceeds, with $25.956 billion remaining capacity under a $21.0 billion offering increase announced on March 23, 2026.
View raw filing on EDGAR →Liftoff Mobile completed a registered public offering of 21,850,000 shares of common stock at $23.00 per share, raising $472.4 million in net proceeds, with proceeds used to repay debt and for general corporate purposes.
View raw filing on EDGAR →West Bay BDC LLC disclosed an unregistered sale of approximately 2.1 million common units for $37.1 million under Item 3.02, relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive private placement to existing investors via capital drawdown notices under subscription agreements, representing a material capital raise that would affect investor assessment of ownership dilution and the company's capital structure.
View raw filing on EDGAR →SUNation Energy entered into a securities purchase agreement on June 7, 2026 to sell 2,390,000 unregistered shares of common stock at $1.13 per share for gross proceeds of $2,700,700 to institutional and accredited investors pursuant to Section 4(a)(2) and Rule 506 exemptions. This is a classic private placement of unregistered equity securities, which is material to investors as it dilutes existing shareholders and signals the company's need to raise capital.
View raw filing on EDGAR →Profusa submitted an Advance Notice on June 8, 2026 to Ascent Partners Fund LLC requesting purchase of common stock under an equity line of credit arrangement. The disclosure describes a dilutive financing mechanism allowing issuance of up to 9.99% of outstanding shares per Advance Notice (capped at $200,000), with pricing based on VWAP and a True-Up Mechanism that could trigger additional share issuance if prices decline. This is a classic equity line of credit (ELOC) arrangement that signals potential dilution and cash-raising activity typical of small-cap issuers under financial pressure.
View raw filing on EDGAR →CleanCore Solutions entered into a Controlled Equity Offering Sales Agreement on June 8, 2026, authorizing the sale of up to $750 million in common stock through Cantor Fitzgerald and Curvature Securities. This is a material dilutive issuance under an at-the-market offering structure (Item 1.01), representing a substantial potential equity raise that would significantly dilute existing shareholders. The filing also discloses termination of a prior ATM agreement and payments to prior agents, confirming the capital-raising intent.
View raw filing on EDGAR →Solidion Technology entered into a Securities Purchase Agreement on June 7, 2026, to issue 750,000 shares of common stock and pre-funded warrants to purchase 1,583,000 additional shares in a private placement under Section 4(a)(2) and Rule 506(b) exemptions, raising approximately $32 million in net proceeds. This unregistered equity issuance materially increases share count and dilutes existing shareholders.
View raw filing on EDGAR →Keystone completed a private placement of 8,468,750 unregistered warrants to the Sponsor and Representatives for $8.47 million in gross proceeds, simultaneously with the IPO closing on June 4, 2026, with favorable terms including cashless exercise and registration rights.
View raw filing on EDGAR →The company completed a private placement of 540,000 units (365,000 to Sponsor and 175,000 to underwriters) at $10.00 per unit, generating $5.4 million in gross proceeds. The units, structured as a non-public offering exempt under Section 4(a)(2) of the Securities Act, include Class A ordinary shares and warrants, creating direct equity dilution.
View raw filing on EDGAR →New Providence Acquisition Corp. III entered into material definitive agreements with co-CEOs Gary Smith and Alexander Coleman to issue $1.5 million in unsecured promissory notes with conversion rights into equity units at $10.00 per unit, creating a dilutive financing arrangement with registration rights that materially affects the registrant's capitalization structure.
View raw filing on EDGAR →Bluejay Diagnostics completed a private placement on June 5, 2026, issuing pre-funded warrants, Series G warrants, and Series H warrants to purchase up to 10,967,751 shares of common stock for approximately $7.7 million in gross proceeds to accredited investors under Section 4(a)(2) and Rule 506.
View raw filing on EDGAR →FutureCorp Space Acquisition 1 completed a private placement of 6,000,000 warrants to the Sponsor and Representative simultaneously with IPO closing, sold at $1.00 per warrant under Section 4(a)(2) exemption. The unregistered sale of equity securities exercisable for Class A ordinary shares is material to investors assessing post-IPO capitalization and ownership structure.
View raw filing on EDGAR →Catheter Precision entered into a Securities Purchase Agreement to acquire 2,941,176 shares of Volato Group common stock for $1,000,000 in a private placement transaction. While this is technically an investment by the Company rather than an issuance of the Company's own securities, the filing is disclosed under Item 1.01 (Material Definitive Agreement) and involves a material equity transaction with significant value ($1M purchase price plus ~$1.1M in consideration received). The transaction is material to investors as it represents a substantial deployment of capital and involves equity securities with inherent valuation risk.
View raw filing on EDGAR →BioCardia sold 3,509,604 shares at $1.279 per share pursuant to an "At The Market" offering agreement with H.C. Wainwright & Co. This is a classic dilutive equity issuance under an ATM facility, which materially increases share count and dilutes existing shareholders. ATM offerings are a standard disclosure category under Item 3.02, though disclosed here under Item 8.01.
View raw filing on EDGAR →Volato Group entered into a Securities Purchase Agreement on June 7, 2026, to sell 6,500,000 shares of Class A common stock at $0.34 per share to institutional investors, raising approximately $2.21 million in gross proceeds. The filing explicitly discloses this under Item 1.01 (Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with the securities offered in reliance on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive private placement that materially increases share count and affects existing shareholders' ownership percentage.
View raw filing on EDGAR →The filing discloses the issuance of 109,588,265 shares of Class A common stock in exchange for 3,870,000 shares of Series C Preferred Stock on June 5, 2026. This represents a massive dilutive equity issuance that increased outstanding shares from approximately 55.3 million to 164.9 million—a nearly 3x increase. The stated purpose was to regain Nasdaq compliance and reduce stockholders' deficit, indicating financial distress. While technically an exchange rather than a cash raise, the economic substance is a highly dilutive issuance to existing shareholders.
View raw filing on EDGAR →